Board of Scientific Counselors

Board of Scientific Counselors

About.jpg

It is the research that Gateway funds that validates our mission. Gateway established the Board of Scientific Counselors (BSC), an external body of renowned cancer researchers to evaluate proposed research and monitor funded research. Members act solely on the basis of a desire to advance the best interests of Gateway and public good. Gateway solicits and receives letters of intent (LOI) and grant applications for cancer research throughout the year. Each LOI and application is reviewed by the members of the BSC.

 

Gateway Board of Scientific Counselors


Nelson Chao, MD, MBA - Chairman
Chief Division of Cell Therapy, Duke University Medical Center

Lise Alschuler, ND, FABNO - Member
Naturopathic Doctor, Naturopathic Specialists

Robert Fine, MD - Member
Director of Experimental Therapeutics, Irving Comprehensive Cancer Center Columbia University

Timothy Fleming, PhD - Member
Senior Scientist, Norton Thoracic Institute

Ann Fonfa - Member
Founder, The Annie Appleseed Project

Judy Fulop, ND, FABNO - Member
Naturopathic Doctor, Northwestern Integrative Medicine

Ronald Morton, Jr., MD, FACS - Member
VP Clinical Sciences, Boston Scientific

Kouros Owzar, PhD - Member
Professor of Biostatistics & Bioinformatics, Duke University Medical Center

Alberto Pappo, MD - Member
Member, St. Jude Faculty; Director, Solid Tumor Division; Co-Leader, Developmental Biology and Solid Tumor Program, St. Jude's Children's Research Hospital

Joseph Pizzorno, Jr., ND - Member
Founder and President Emeritus, Bastyr University

Mary Lou Smith, JD - Member
Co-Founder, Research Advocacy Network

Rich Rieger - Member
Vice President, Business Development at Horizon Pharma

99 cents of every dollar received directly funds cancer clinical trials

53

Current Gateway-funded clinical trials

150+

Clinical trials funded at leading institutions worldwide

$16.56

Funds one patient for one day at a Gateway-funded clinical trial

 
 

Mission Partners